Barclays maintains Equalweight on Integra LifeSciences (NASDAQ: IART), price target of $42.00 (from $84.00).Analyst Matthew Taylor comments "In our view ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE